SPRY

Beyond's analysis on SPRY

• 2026-08-28 — Rosen Law Firm reminds SPRY shareholders of October 5 lead plaintiff deadline in securities fraud class action alleging misleading CVS Caremark formulary timeline for neffy
• 2026-08-25 — Investors get chance to serve as lead plaintiffs in ARS Pharmaceuticals securities fraud lawsuit
• 2026-08-17 — Rosen Law Firm launches a securities fraud class action against ARS Pharmaceuticals, exposing the company to potential legal costs and share‑price pressure
• 2026-08-07 — Investors of ARS Pharmaceuticals have a window to lead a securities fraud class action over alleged misleading statements about CVS Caremark formulary timing

Recent news mentioning SPRY

• 2026-09-08 — SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
• 2026-09-08 — ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
• 2026-09-06 — SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
• 2026-09-03 — SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm
• 2026-09-02 — SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
• 2026-09-02 — SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
• 2026-08-31 — SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
• 2026-08-31 — ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
• 2026-08-28 — SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
• 2026-08-27 — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
• 2026-08-27 — SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY
• 2026-08-26 — Levi & Korsinsky Reminds ARS Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY

Appears alongside

• ARS
• SueWallSt
• SBS
• DJS
• ALERT
• LLP

Browse the full archive →